2728667-27-2 ((Zongertinib)

宗尔替尼BI-1810631;

2-Propenamide, N-[1-[8-[[3-methyl-4-[(1-methyl-1H-benzimidazol-5-yl)oxy]phenyl]amino]pyrimido[5,4-d]pyrimidin-2-yl]-4-piperidinyl]-;Zongertinib;WLZ3778;2728667-27-2;Zongertinib (JAN/USAN/INN);zongertinib [INN];CHEMBL5314498;N-[1-(8-{3-methyl-4-[(1-methyl-1H-1,3-benzimidazol-5- yl)oxy]anilino}pyrimido[5,4-d]pyrimidin-2-yl)piperidin-4- yl]prop-2-enamide;HY-148810;N-[1-[4-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]pyrimido[5,4-d]pyrimidin-6-yl]piperidin-4-yl]prop-2-enamide;DRH7R67UVL;DA-59312;G65208;N-(1-(8-((3-methyl-4-((1-methyl-1H-benzo[d]imidazol-5-yl)oxy)phenyl)amino)pyrimido[5,4-d]pyrimidin-2-yl)piperidin-4-yl)acrylamide;GLXC-27939;TS-09568;NSC854531;SCHEMBL23957509;GTPL12387;example I-01 [WO2021213800A1];NSC-854531;ZONGERTINIB [USAN];CS-0641245;EX-A8033;Zongertinib?;BI1810631;BI-1810631;D12879;

YSGNGFPNTLERCR-UHFFFAOYSA-N

1S/C29H29N9O2/c1-4-26(39)34-19-9-11-38(12-10-19)29-30-15-23-27(36-29)28(32-16-31-23)35-20-5-8-25(18(2)13-20)40-21-6-7-24-22(14-21)33-17-37(24)3/h4-8,13-17,19H,1,9-12H2,2-3H3,(H,34,39)(H,31,32,35)

C(NC1CCN(C2=NC=C3N=CN=C(NC4=CC=C(OC5=CC=C6N(C)C=NC6=C5)C(C)=C4)C3=N2)CC1)(=O)C=C